ORI
VRTX icon

Oak Ridge Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Oak Ridge Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,009
Closed -$897K – 197
2026
Q1 		$897K Sell
2,009
-931
-32% -$434K 0.06% 128
2025
Q4 		$1.33M Buy
2,940
+1,126
+62% +$485K 0.08% 116
2025
Q3 		$710K Sell
1,814
-2
-0.1% -$836 0.05% 137
2025
Q2 		$808K Sell
1,816
-17
-0.9% -$7.83K 0.06% 125
2025
Q1 		$889K Sell
1,833
-75
-4% -$35K 0.07% 118
2024
Q4 		$768K Buy
1,908
+81
+4% +$37.5K 0.06% 125
2024
Q3 		$850K Buy
1,827
+5
+0.3% +$2.4K 0.07% 119
2024
Q2 		$854K Sell
1,822
-77
-4% -$33.4K 0.08% 121
2024
Q1 		$794K Sell
1,899
-16
-0.8% -$6.76K 0.08% 127
2023
Q4 		$779K Sell
1,915
-32
-2% -$11.8K 0.09% 128
2023
Q3 		$677K Sell
1,947
-251
-11% -$87.8K 0.09% 129
2023
Q2 		$773K Buy
+2,198
New +$741K 0.1% 129
2021
Q1 		– Sell
-14,968
Closed -$3.54M – 182
2020
Q4 		$3.54M Sell
14,968
-6,027
-29% -$1.38M 0.31% 103
2020
Q3 		$5.71M Sell
20,995
-300
-1% -$82.8K 0.44% 81
2020
Q2 		$6.18M Sell
21,295
-335
-2% -$90.8K 0.52% 76
2020
Q1 		$5.15M Sell
21,630
-163
-0.7% -$37.4K 0.53% 74
2019
Q4 		$4.77M Sell
21,793
-938
-4% -$190K 0.35% 95
2019
Q3 		$3.85M Buy
22,731
+549
+2% +$97.1K 0.29% 99
2019
Q2 		$4.07M Sell
22,182
-2,717
-11% -$475K 0.28% 103
2019
Q1 		$4.58M Buy
+24,899
New +$4.6M 0.29% 106

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

Oak Ridge Investments's VRTX Position: Q2 2026 in Review

Oak Ridge Investments sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 2,009 shares — an estimated $897K sold.

Oak Ridge Investments first reported a position in VRTX in Q1 2019 and held it in 20 quarters. The position peaked at $6.18M in Q2 2020. 368 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Oak Ridge Investments reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Oak Ridge Investments sold 2,009 Vertex Pharmaceuticals shares in Q2 2026, an estimated $897K.
  • Oak Ridge Investments first reported a position in Vertex Pharmaceuticals in Q1 2019 and held it in 20 quarters.
  • Oak Ridge Investments's Vertex Pharmaceuticals position peaked at $6.18M in Q2 2020.
  • 368 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Oak Ridge Investments's 13F filing for Q2 2026, filed 21 Jul 2026.